A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both ...

Doctors diagnosed Ellington with stage 4 small cell lung cancer in 2024. Her initial prognosis was a life expectancy of two to three months after chemo, and immunotherapy was unsuccessful in targeting ...

Liver fibrosis is a major global health concern, developing as a result of chronic liver diseases (CLDs) such as viral ...

Two new drugs to treat prostate and liver cancer have been given the green light for use by the NHS in Scotland. The Scottish ...

Bristol Myers BMY announced that the European Commission (EC) has approved the blockbuster immuno-oncology drug Opdivo ...

Gleneagles Hospital Hong Kong (Gleneagles) is excited to be the first private hospital in Asia to offer Histotripsy treatment, the transformative and non-invasive technology that uses high-intensity ...

Marwan G. Fakih, MD, discusses the next steps for the clinical development of the balstilimab plus botensilimab in ...

Scientists discovered a way to block hepatitis B infection using an anticancer drug, offering hope for new treatments.

Throughout the 45-minute procedure of vascular embolization, a 70-year-old man sang 10 songs to “drown out the pain”, dedicating them to his doctors.

Ashley Robinson, 35, told doctors about his family history of colon cancer, but says they insisted he was "too young” for the ...

The European Commission approved Opdivo plus Yervoy for first-line treatment of advanced liver cancer, citing significant ...

Bristol Myers Squibb has won the European Commission's expanded approval of its Opdivo plus Yervoy cancer-drug combination for early use in certain patients with liver cancer. Bristol Myers on Friday ...